Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
N/A
37,727 New
37,727 $0
Q1 2024

May 15, 2024

BUY
N/A
13,000 New
13,000 $0

Others Institutions Holding ACRV

About Acrivon Therapeutics, Inc.


  • Ticker ACRV
More about ACRV
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.